Building a Pre-Disease Data Map
October 7, 2026
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
2 min read
False
Advertisement
Future of Pharma
The Resilience Prescription
October 2, 2026
We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty
5 min read
How Companion Diagnostics Can Support Targeted Drug Launches
By Jane Li
September 29, 2026
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
5 min read
What Do Scientists Want from AI?
September 14, 2026
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
5 min read
What Will Drug Development Look Like in 2036?
September 3, 2026
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
7 min read
What Did ASCO 2026 Reveal About the Future of Oncology?
By James Strachan
August 6, 2026
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades
8 min read
Do Pharma Supply Chains Have a Visibility Problem?
By Adriana Stalteri
August 4, 2026
A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain
4 min read
2026 Innovation Awards: Nominate Now
July 31, 2026
Nominations are now open for The Medicine Maker 2026 Innovation Awards, celebrating the latest technologies for drug development and manufacturing
1 min read
The Power List 2026 is Live
July 21, 2026
We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality
2 min read
AI in Drug Development: Moving Beyond Early Use Cases
By Crystal Allard, Pratyusha Pallavi
June 10, 2026
As new rules take hold, what does “good AI practice” look like in drug development?
6 min read
